Ribometrix Inc.

Ribometrix is a drug-discovery company leading a new paradigm in small molecule therapeutics that modulate RNA biology. We are committed to improving the lives of patients and families by developing therapies through innovative science. We are accountable for our actions and results. Meet the Ribometrix team, where every individual is valued as part of a collaborative community sharing a common focus on advancing the field of modulating RNA biology to discover and develop transformative small-molecule drugs. We are a team of individuals driven by the spirit of innovation, collaboration, empowerment, and integrity who are committed to the goal of helping patients with our novel therapeutic approach. Ribometrix is leading a new drug-discovery paradigm: using small molecules to target RNA biology and prevent the production of proteins that drive disease. Ribometrix is a unique opportunity to trailblaze the next frontier in drug discovery. Our industry-leading drug discovery platform enables us to leverage RNA structure determination and state-of-the art RNA tools and technologies to directly target and modulate RNA biology.